European Archives - Page 158 of 1146 - European Medical Journal

Infertility Without Treatment Linked to Autoimmune Disease Risk

Women who experienced infertility without fertility treatment had a higher incidence of systemic autoimmune rheumatic disease…

Metformin Does Not Affect Prostate Cancer Progression Rates

Despite promising preclinical and epidemiological data, metformin does not appear to impact disease progression in men with low-risk prostate cancer.

Mailed Faecal Immunochemical Testing Boosts CRC Screening Rates

A centralised, mailed colorectal cancer screening programme significantly improved screening completion rates in federally qualified health centres.

Whole-Body MRI in Oncology

Whole-body magnetic resonance imaging (WB-MRI) has significantly improved oncological disease management by enabling comprehensive…

Atopic Dermatitis as a Risk Factor for Inflammatory Bowel Disease

Shared genetic, environmental, and microbial factors suggest a potential relationship between these diseases.

Alpha Blockers Linked to Fracture Risk in Female Patients With Chronic Kidney Disease

Alpha blockers increase fracture risk in female CKD patients treated for voiding dysfunction, emphasising the need for cautious prescribing.

Gold crown on blue background

Could Eli Lilly take the crown in the obesity market?

According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.

African American Men Respond Better to Ra-223 Treatment

African American men with mCRPC may experience better outcomes than white men when treated with radium-223 dichloride.

Human versus Machine: Navigating Clinical Safety

In this episode, Jonathan Sackier sits down with Tom Bradshaw to explore the rapidly evolving landscape of digital health. They discuss Bradshaw’s expertise in the clinical application of AI and digital technologies, his work with the NHS and private sector firms, and more.

Cutting Blood Loss: Hypovolaemic Phlebotomy in Liver Surgery

The study’s findings demonstrate that hypovolaemic phlebotomy effectively reduces the need for red blood cell transfusions.